Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-1999 | 10-1998 | |
| Sales | 2,600 | 3,100 |
| Cost of Goods | 1,500 | 1,700 |
| Gross Profit | 1,100 | 1,400 |
| Operating Expenses | 1,800 | 1,500 |
| Operating Income | -700 | -100 |
| Other Income | 700 | 100 |
| Net Income Continuous | -800 | -100 |
| Net Income | $-800 | $-100 |
| EPS Basic Total Ops | -0.05 | -0.01 |
| EPS Basic Continuous Ops | -0.05 | -0.01 |
| EPS Diluted Total Ops | -0.05 | -0.01 |
| EPS Diluted Continuous Ops | -0.05 | -0.01 |
| EBITDA(a) | $-500 | $100 |